Astrazeneca Pharmaceuticals LP

DE · United States · Reporting entity ID 100000000146

Total reported 2019–2025

$2.97B

#6 of 2,960 reporting companies — 3.6% of all reported industry payments

$455.9M in general payments across 3,228,979 records, plus $2.51B in research funding across 43,708 records.

How it breaks down

General payments $455,882,965

Research funding $2,513,126,992

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.